Primary Leiomyosarcoma of the Breast: A Case with Rapidly Progressive Clinical Course
Abstract
Abstract Introduction Primary leiomyosarcoma (LMS) of the breast is an exceptionally rare mesenchymal malignancy that accounts for <0.0006% of all breast neoplasms. Owing to its rarity and the nonspecific nature of conventional imaging, achieving an accurate preoperative diagnosis is often difficult. Case Presentation We report the case of a 59-year-old woman who presented with a rapidly enlarging right breast mass. Clinical and radiographic evaluations revealed a large, irregular tumor involving the entire breast parenchyma (17 × 16 × 12 cm), without evidence of axillary lymphadenopathy or distant metastasis. A core needle biopsy revealed a malignant spindle cell neoplasm. The patient subsequently underwent total mastectomy with axillary sampling and skin grafting. Histological examination revealed a high-grade tumor composed of pleomorphic spindle cells with hemorrhage and necrosis. Immunohistochemical profiling showed that the tumor was negative for epithelial markers (AE1/AE3, EMA, and CAM5.2). However, the diffuse expression of α-smooth muscle actin and focal weak positivity for h-caldesmon confirmed a smooth muscle lineage. The Ki-67 labeling index was 50–60%. No lymph node metastasis was observed. Despite receiving adjuvant radiotherapy, the patient developed multiple pulmonary metastases 6 months post-surgery. Conclusion Primary breast LMS remains a diagnosis of exclusion, requiring differentiation from metaplastic carcinoma, phyllodes tumor, and metastatic sarcoma. Complete surgical resection remains the mainstay of treatment, and tumor size, grade, and Ki-67 index are critical prognostic factors.